Jubilant Life Sciences up 5% on talk of green panel for pesticide project
The stock of an integrated global pharmaceutical and life sciences company has rallied 14% in past three trading sessions.
 "Jubilant Life Sciences up 5% on talk of green panel for pesticide project")
premium
Jubilant Life Sciences was up 5% to Rs 729 on the BSE in early noon deals after media report suggested that the company’s pesticide project in Gujarat got the green panel nod.
The stock of an integrated global pharmaceutical and life sciences company has rallied 14% in past three trading sessions.
The BSE said that the Exchange has sought clarification from Jubilant Life Sciences on December 04, 2017 with reference to news appeared in www.business-standard.com dated December 03, 2017 quoting "Green panel nod to Jubilant Life's Rs 250-cr pesticide project in Gujarat".
The reply is awaited.
“The Centre's green panel has given the go-ahead to Jubilant Life Sciences for setting up a technical grade pesticide manufacturing unit in Gujarat, which would entail an investment of Rs 250 crore,” the PTI report suggested.
The proposed unit will be set up in an area of 20 hectares in Vagra taluk of Bharuch district, it added. CLICK HERE TO READ FULL REPORT.
The stock of an integrated global pharmaceutical and life sciences company has rallied 14% in past three trading sessions.
The BSE said that the Exchange has sought clarification from Jubilant Life Sciences on December 04, 2017 with reference to news appeared in www.business-standard.com dated December 03, 2017 quoting "Green panel nod to Jubilant Life's Rs 250-cr pesticide project in Gujarat".
The reply is awaited.
“The Centre's green panel has given the go-ahead to Jubilant Life Sciences for setting up a technical grade pesticide manufacturing unit in Gujarat, which would entail an investment of Rs 250 crore,” the PTI report suggested.
The proposed unit will be set up in an area of 20 hectares in Vagra taluk of Bharuch district, it added. CLICK HERE TO READ FULL REPORT.
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%